{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/digital-solutions-oncology-peer-reviewed-journal-article-featuring-fortrea-oncologists#webpage",
"url": "https://www.fortrea.com/insights/digital-solutions-oncology-peer-reviewed-journal-article-featuring-fortrea-oncologists",
"name": "Head and Neck Cancer: Peer-reviewed Journal Article Featuring Fortrea Oncologists",
"description": "This Fortrea peer-reviewed info sheet explores head and neck cancer biomarkers within the context of biomarker-driven precision immunotherapy and oncology clinical research. The content focuses on the role of molecular profiling, immuno-oncology biomarkers, and translational oncology research in improving patient selection and treatment response in head and neck squamous cell carcinoma. It highlights how biomarker-driven oncology trials support personalized treatment pathways, enabling more precise application of immunotherapy and targeted therapies in complex cancer cases. The page emphasizes peer-reviewed scientific contributions from Fortrea oncologists, showcasing research that integrates clinical trial data, biomarker analysis, and precision medicine approaches to advance oncology outcomes. By combining head and neck cancer biomarkers, immunotherapy research, and translational clinical trial evidence, the content demonstrates how biomarker-guided strategies are shaping modern precision oncology and improving decision-making in cancer treatment development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Head and Neck Cancer: Peer-reviewed Journal Article Featuring Fortrea Oncologists",
"item": "https://www.fortrea.com/insights/head-and-neck-cancer-peer-reviewed-journal-article-featuring-fortrea-oncologists"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/head-and-neck-cancer-peer-reviewed-journal-article-featuring-fortrea-oncologists#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/head-and-neck-cancer-peer-reviewed-journal-article-featuring-fortrea-oncologists#webpage"
},
"headline": "Head and Neck Cancer Biomarkers: Biomarker-Driven Precision Immunotherapy in Oncology Clinical Trials| Fortrea Info Sheet",
"description": "This Fortrea peer-reviewed info sheet explores head and neck cancer biomarkers within the context of biomarker-driven precision immunotherapy and oncology clinical research. The content focuses on the role of molecular profiling, immuno-oncology biomarkers, and translational oncology research in improving patient selection and treatment response in head and neck squamous cell carcinoma. It highlights how biomarker-driven oncology trials support personalized treatment pathways, enabling more precise application of immunotherapy and targeted therapies in complex cancer cases. The page emphasizes peer-reviewed scientific contributions from Fortrea oncologists, showcasing research that integrates clinical trial data, biomarker analysis, and precision medicine approaches to advance oncology outcomes. By combining head and neck cancer biomarkers, immunotherapy research, and translational clinical trial evidence, the content demonstrates how biomarker-guided strategies are shaping modern precision oncology and improving decision-making in cancer treatment development.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-12",
"dateModified": "2025-07-12",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-07/head-neck-cancer-peer-reviewed-fortrea-oncologists.pdf",
"encodingFormat": "application/pdf"
}
}
]
}